Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine versus intranasal midazolam for pediatric VSD catheter closure
PACTR202305793236698Phase 2Recruiting
- Sponsor
- yasmin abdelrazek
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and midazolam in Cardiovascular Malformation (CVM) and Ventricular Septal Defect (VSD) (2 arms), sponsored by yasmin abdelrazek. Started Apr 2023; status: recruiting.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
Cardiovascular Malformation (CVM)Ventricular Septal Defect (VSD)
Beyond the preview
Go deeper on PACTR202305793236698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202305793236698.